Reviva Pharmaceuticals
RVPH
RVPH
16 hedge funds and large institutions have $4.68M invested in Reviva Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
2
Calls
$230K
Puts
$25K
Net Calls
+$205K
Net Calls Change
+$205K
Top Buyers
Top Sellers
1 |
AC
Armistice Capital
New York
|
-$2.05M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$71.1K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.7K |
4 |
UBS Group
Zurich,
Switzerland
|
-$6K |
5 |
BlackRock
New York
|
-$4.89K |